semaglutide and heart disease cardiovascular outcomes align more closely with attained dose than achieved weight loss Semaglutide breakthrough: new hope for

4 Semaglutide (Ozempic, Wegovy): 86.4% of study participants lost at least 5% body weight

Some people, like Sam, have always exercised and viewed GLP-1s as an extra push to help them reach their weight goals

The impact of left atrial size on long-term outcome of catheter ablation of chronic atrial fibrillation

Its worth noting that no completed, large, head-to-head trial directly comparing Wegovy 7.2mg with Mounjaro 15mg exists yet

For detailed information about expected results throughout this journey, read our complete guide to tirzepatide weight loss results month by month

Its a DPP-4 (dipeptidyl peptidase-4) inhibitor, meaning it blocks the enzyme DPP-4, which normally breaks down the bodys GLP-1 and GIP hormones